Bayer AG (BUD:BAYER) FFO


BUD:BAYER Bayer AG BUD:BAYER
53 GF Score
Price Ft18,450.00
GF Value Ft10,451.54
Valuation Significantly Overvalued
! 7 Warning Signs
View Full Analysis

What is Bayer AG FFO?

FFO (Funds from operations) only applies to REITs.

BUD:BAYER
53GF Score
Bayer AG BUD:BAYER
FFO is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Bayer AG (BUD:BAYER) Overvalued in 2026?

Based on GuruFocus' analysis, Bayer AG stock appears to be overvalued. The current stock price of Ft18,450.00 is trading 76.5% above its estimated GF Value™ of Ft10,451.54. GuruFocus considers Bayer AG to be Significantly Overvalued.

Key valuation signals for BUD:BAYER:

  • FFO:
  • GF Value™: Ft10,451.54 vs. price of Ft18,450.00 (76.5% above fair value)
  • GF Score™: 53/100 with 7 warning signs

No single metric tells the full story. See the BUD:BAYER stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Bayer AG Business Description

Address Kaiser-Wilhelm-Allee 1, Leverkusen, NW, DEU, 51368
Bayer is a German healthcare and agriculture conglomerate. Healthcare provides close to half of the company's sales and includes pharmaceutical drugs (about 38% of total sales in 2025) as well as vitamins and other consumer healthcare products (13% of total). The firm's crop science business (47% of total) sells seeds, pesticides, herbicides, and fungicides, which was expanded through its 2018 acquisition of Monsanto.
53GF Score

Get the complete analysis for BUD:BAYER

FFO is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

Ft18,450.00
Price
Ft10,451.54
GF Value